• bjoernmannsfeld

Study: Cannabis Extract Effective in Patients with Refractory Chronic Pain


August 18, 2022 Sydney, Australia: The administration of cannabis extracts containing equal quantities of THC and CBD is associated with reduced pain intensity and improved sleep in patients with chronic refractory pain conditions, according to data published in the journal Medical Cannabis and Cannabinoids.


Australian investigators assessed the safety and efficacy of whole-plant cannabis oil in a cohort of 151 chronic pain patients. Participants in the trial used the extract daily for at least three months. All of the subjects in the trial suffered from conditions that were unresponsive to conventional analgesics, such as opioids and NSAIDs (non-steroidal anti-inflammatory drugs). Trial subjects were most likely to be diagnosed with neuropathy, musculoskeletal pain, or arthritis.